Basic Study
Copyright ©The Author(s) 2021.
World J Hepatol. Feb 27, 2021; 13(2): 187-217
Published online Feb 27, 2021. doi: 10.4254/wjh.v13.i2.187
Table 1 METAVIR scores and description of clinical liver samples
METAVIR score

Patients (n)
Pathology
F0-F1No fibrosis or mild fibrosis10HBV-, HCV-, HIV-seronegative patients who underwent liver resection surgery, mainly for liver metastasis, in the absence of underlying liver disease. A0-F1
F0-F1No fibrosis or mild fibrosis1Prior history: Breast cancer with liver metastases, treated by surgery and radio-chemotherapy. Non-tumoral liver sample: Perisinusoidal and portal fibrosis without septa (F1). No steatosis
2Prior history: HCV infection, resected hepato-cholangiocarcinoma. Non tumoral liver samples: A0F0
F2-F3Moderate to severe fibrosis2Cholangiocarcinoma, non-tumor liver samples
1Chronic hepatitis B infection, NASH, and two resected hepatocellular carcinoma nodules. Non-tumoral liver sample: Chronic hepatitis with extensive fibrosis A1F3
F4Cirrhosis2HCC, non-tumor liver samples
1HCC, treated HCV infection. Non-tumoral liver sample
1HCC on untreated HCV infection. Non-tumoral liver sample